Activist hedge fund builds stake in Ozempic-maker Novo Nordisk

Why is Warner Bros. Discovery splitting into two companies? How will the National Guard deployment impact LA protests? What’s driving Apple’s stock drop after WWDC event? Why did Disney pay less for full control of Hulu? How are US-China trade talks affecting markets today? What caused Sunnova Energy’s bankruptcy in solar sector? Why is Amazon investing $20 billion in Pennsylvania data centers?

Activist hedge fund builds stake in Ozempic-maker Novo Nordisk

ft.com/content/d8ae2ef0-6165-4cb9-8eab-d28efa95b00f

Activist hedge fund builds stake in Ozempic-maker Novo Nordisk
Then $75 per month. Complete digital access to quality FT journalism on any device. Cancel anytime during your trial.
Discover all the plans currently available in your country

This story appeared on ft.com, 2025-06-09 18:04:53.273000.